Cargando…

Sex differences in atrial fibrillation: patient-reported outcomes and the persistent toll on women

BACKGROUND: Women have worse patient-reported outcomes in atrial fibrillation (AF) than men, but the reasons remain poorly understood. We investigated how comorbid conditions, treatment, social factors, and their modification by sex would attenuate sex-specific differences in patient-reported outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Raisa L., Guhl, Emily N., Althouse, Andrew D., Herbert, Brandon, Sharbaugh, Michael, Essien, Utibe R., Hausmann, Leslie R.M., Magnani, Jared W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435986/ https://www.ncbi.nlm.nih.gov/pubmed/34541565 http://dx.doi.org/10.1016/j.ajpc.2021.100252

Ejemplares similares

Association of income and health-related quality of life in atrial fibrillation
por: Guhl, Emily, et al.
Publicado: (2019)

Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation
por: Omole, Toluwa D., et al.
Publicado: (2022)

Association of income and educational attainment in hospitalization events in atrial fibrillation
por: Tertulien, Tarryn, et al.
Publicado: (2021)

Association of Fine Particulate Matter and Risk of Stroke in Patients With Atrial Fibrillation
por: Rhinehart, Zachary J., et al.
Publicado: (2020)

Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
por: Essien, Utibe R., et al.
Publicado: (2021)

The Atrial Fibrillation Health Literacy Information Technology Trial: Pilot Trial of a Mobile Health App for Atrial Fibrillation
por: Guhl, Emily, et al.
Publicado: (2020)

Analysis of Initiating Anticoagulant Therapy for Atrial Fibrillation Among Persons Experiencing Homelessness in the Veterans Affairs Health System
por: Wilson, David A., et al.
Publicado: (2022)

Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation
por: Guo, Jingchuan, et al.
Publicado: (2021)

COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
por: Hernandez, Inmaculada, et al.
Publicado: (2023)

Separate and Unequal: The Cost of Coronavirus Disease 2019 on Childhood Health and Well-Being
por: Magnani, Jared W., et al.
Publicado: (2021)

Association of patient-reported outcomes with hospitalization risk in atrial fibrillation
por: Chen, Yimin, et al.
Publicado: (2021)

Trends in atrial fibrillation hospitalizations in the United States: A report using data from the National Hospital Discharge Survey
por: Nisar, Muhammad Umer, et al.
Publicado: (2017)

Association of Race and Ethnicity on the Management of Acute Non−ST‐Segment Elevation Myocardial Infarction
por: Tertulien, Tarryn, et al.
Publicado: (2022)

Cross-talk between macrophages and atrial myocytes in atrial fibrillation
por: Sun, Zewei, et al.
Publicado: (2016)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries
por: Hanna, Jonathan, et al.
Publicado: (2022)

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)
por: Coll-Vinent, Blanca, et al.
Publicado: (2017)

Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health Administration
por: Boyer, Taylor L., et al.
Publicado: (2023)

Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
por: Alberts, Mark, et al.
Publicado: (2020)

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
por: De Marchis, Gian Marco, et al.
Publicado: (2023)

Ideal Cardiovascular Health Metrics in Couples: A Community‐Based Study
por: Erqou, Sebhat, et al.
Publicado: (2018)

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

Sex differences involved in persistent atrial fibrillation recurrence after radiofrequency ablation
por: Li, Haiwei, et al.
Publicado: (2022)

Lifetime healthcare expenses across demographic and cardiovascular risk groups: The application of a novel modeling strategy in a large multiethnic cohort study
por: Khera, Rohan, et al.
Publicado: (2023)

Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillation
por: Hoffmann, Sandra, et al.
Publicado: (2016)

Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis
por: Reddin, Catriona, et al.
Publicado: (2021)

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2022)

Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry
por: Yoshimoto, Takeshi, et al.
Publicado: (2022)

European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation
por: Haywood, G.A., et al.
Publicado: (2020)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review
por: Yiin, Gabriel S.C., et al.
Publicado: (2019)

Associations of dietary patterns with risk of incident atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS)
por: Garg, Parveen K., et al.
Publicado: (2023)

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care
por: Goette, Andreas, et al.
Publicado: (2015)

Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation
por: Canpolat, Uğur
Publicado: (2016)

Virtual Ablation of Atrial Fibrillation in Patients With Persistent Atrial Fibrillation: An Unexplored Niche
por: Choi, Eue-Keun
Publicado: (2022)

Ablation Therapy for Persistent Atrial Fibrillation
por: Ifedili, Ikechukwu, et al.
Publicado: (2022)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0rpipqq7hcuufs42q6vlu5c139